Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nur-Vaizura Mohamad"'
Autor:
Nur-Vaizura Mohamad
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1403 (2023)
Tocotrienols have higher medicinal value, with multiple sources of evidence showing their biological properties as antioxidant, anti-inflammatory, and osteoprotective compounds. However, tocotrienol bioavailability presents an ongoing challenge in it
Externí odkaz:
https://doaj.org/article/de6c07d0401544bcae8dc1107fcf7963
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 137, Iss , Pp 111368- (2021)
Tocotrienol has been shown to prevent bone loss in animal models of postmenopausal osteoporosis, but the low oral bioavailability might limit its use. A self-emulsifying drug delivery system (SEDDS) could increase the bioavailability of tocotrienol.
Externí odkaz:
https://doaj.org/article/3e4370b317c74cb4bc1050635ddb859e
Autor:
Sok Kuan Wong, Yusof Kamisah, Norazlina Mohamed, Norliza Muhammad, Norliana Masbah, Nur Azlina Mohd Fahami, Isa Naina Mohamed, Ahmad Nazun Shuid, Qodriyah Mohd Saad, Azman Abdullah, Nur-Vaizura Mohamad, Nurul’ Izzah Ibrahim, Kok-Lun Pang, Yoke Yue Chow, Benjamin Ka Seng Thong, Shaanthana Subramaniam, Chin Yi Chan, Soelaiman Ima-Nirwana, Kok-Yong Chin
Publikováno v:
Nutrients, Vol 12, Iss 1, p 259 (2020)
Tocotrienol (T3) is a subfamily of vitamin E known for its wide array of medicinal properties. This review aimed to summarize the health benefits of T3, particularly in prevention or treatment of non-communicable diseases (NCDs), including cardiovasc
Externí odkaz:
https://doaj.org/article/044775d0484149b68e6f563e24c0ee67
Autor:
Sok Kuan Wong, Nur-Vaizura Mohamad, Tijjani Rabiu Giaze, Kok-Yong Chin, Norazlina Mohamed, Soelaiman Ima-Nirwana
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2587 (2019)
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal fracture, and increased mortality. Bone provides a hospitable microenvironment to tumor cells. The disease manifestation is driven by the interaction
Externí odkaz:
https://doaj.org/article/1ceb01fb402c4783a2cc9b18d1124841
Autor:
Sok Kuan Wong, Nur-Vaizura Mohamad, Nurul ‘Izzah Ibrahim, Kok-Yong Chin, Ahmad Nazrun Shuid, Soelaiman Ima-Nirwana
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 6, p 1453 (2019)
Bone remodelling is a tightly-coordinated and lifelong process of replacing old damaged bone with newly-synthesized healthy bone. In the bone remodelling cycle, bone resorption is coupled with bone formation to maintain the bone volume and microarchi
Externí odkaz:
https://doaj.org/article/cf26e0fdbfd84084a60afe669baf3d78
Publikováno v:
International Journal of Medical Sciences
Menopause is the leading cause of osteoporosis for elderly women due to imbalanced bone remodelling in the absence of oestrogen. The ability of tocotrienol in reversing established bone loss due to oestrogen deficiency remains unclear despite the ple
Publikováno v:
Endocrine, Metabolic & Immune Disorders Drug Targets
Osteoporosis is one of the major health issues associated with menopause-related estrogen deficiency. Various reports suggest that the hormonal changes related to menopausal transition may lead to the derangement of redox homeostasis and ultimately o
Autor:
Nur-Vaizura Mohamad, Azlan Mohd Arlamsyah, Sok Kuan Wong, Kok-Yong Chin, Rahma Triliana, Ima Nirwana Soelaiman, Rhivaldy Faahim Kamalulloh, Benjamin Ka Seng Thong
Publikováno v:
Drug Design, Development and Therapy. 14:2561-2572
Purpose Prolonged use of proton pump inhibitors may cause bone loss, and limited therapeutic agents are available to prevent this skeletal side effect. The combination of annatto tocotrienol, a bone anabolic agent, with calcium presents a novel strat
Publikováno v:
Endocrine, metabolicimmune disorders drug targets. 21(10)
Prolonged treatment with Gonadotropin-Releasing Hormone (GnRH) agonists is known to induce bone loss among prostate cancer patients. However, evidence on the skeletal effects of GnRH antagonists is relatively less well-known. This review aims to exam
Autor:
Wan Nuraini Wan Hasan, Mohd Fozi Nur-Farhana, Soelaiman Ima-Nirwana, Nur-Vaizura Mohamad, Kok-Yong Chin, Sok Kuan Wong, James Jam Jolly
Publikováno v:
The Aging Male. 22:129-140
Testosterone is the predominant gonadal androgen in men. Low testosterone levels are found to be associated with an increased in metabolic risk and systematic inflammation. Since adipose tissue is a source of inflammatory cytokines, testosterone may